COMMUNICATION
|
doi:10.20944/preprints202009.0702.v1
Subject:
Life Sciences,
Biochemistry
Keywords:
SARS-CoV-2; influenza vaccine; systematic review; infection; severity; risk
Online: 29 September 2020 (09:14:03 CEST)